Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Emergence Excitement in Orthognathic Surgery
NCT01524367Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Oct 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in emergence delirium (ED), sponsored by Yonsei University. Primary endpoint: Richmond Agitation-Sedation Scale at 2 hours. Started Oct 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT01524367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524367.